Physician profile
Daniel Kennedy
NPI 1437560281
$1,001.43
in general payments reported to CMS, 2019-2025
11 companies · $572 in 2025
The $572 reported for 2025 was more than what 80% of Diagnostic Radiology providers received nationally (typical 2025 total: $112).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $146 · 2022: $232 · 2024: $51.64 · 2025: $572.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $624.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $623.54 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $250.99 | 2022-2025 | Merlin@Home |
| Boston Scientific Corporation | $180.59 | 2025 | Watchman Access System, Latitude Communicator Power Supply |
| Pfizer INC. | $143.98 | 2019-2025 | |
| Abiomed | $138.37 | 2024-2025 | Impella |
| Novo Nordisk INC | $93.14 | 2025 | Wegovy |
| Stryker Corporation | $72.81 | 2025 | Artix Mt, Flowtriever, Clottriever Bold Catheter |
| Regeneron Healthcare Solutions, INC. | $45.13 | 2025 | Evkeeza |
| Amgen INC. | $21.77 | 2019 | |
| Ge Healthcare | $18.95 | 2025 | |
| Davol INC. | $18.71 | 2024 | Channel Drain |
| Janssen Pharmaceuticals, INC | $16.99 | 2024 | Xarelto |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Kennedy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.